Skip to main content

MoneyWorks4Me

Cadila Healthcare informs about press release

30 Jun 2018 Evaluate

Cadila Healthcare has informed about press release titled, 'Zydus receives final approval from the USFDA for Triamterene and Hydrochlorothiazide Tablets USP'.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1913.25
Dr. Reddys Labs. 1387.00
Cipla 1410.85
Lupin 2015.35
Zydus Lifesciences 1218.90
View more..